Role of Nutraceuticals in the Treatment of Degenerative Osteoporosis or Disc Disease

Degenerative disc disease (DDD) is a common condition affecting the intervertebral disc and vertebral bodies, particularly in the lumbar spine, and it is often diagnosed in early to middle age. Osteoblasts and osteoclasts play a crucial role in bone remodeling, which preserves metabolic balance and skeletal integrity. After the old or injured bone has been reabsorbed, new bone material is deposited. Osteocytes regulate bone formation, collagen breakdown, hormonal signals, mechanical strain, and remodeling site and timing. A reduction in bone density may result from imbalances. Commonly, it is associated with various factors, such as genetics, obesity, diabetes, smoking, physical strain, discogenic pain, and gene polymorphisms. Modern medical technologies can help identify encouraging variables to prevent DDD. However, many people do not receive early diagnosis and treatment. Hence, understanding the underlying cellular mechanisms of the inflammatory response can significantly enhance the prevention and treatment of DDD. Additionally, lifestyle modifications like maintaining a healthy diet, exercising regularly, quitting smoking and alcohol, and monitoring DDD-promoting variables can help reduce its incidence. As a consequence of their anti-inflammatory and antioxidant qualities, phytoconstituents produced from plants have drawn interest for their possible therapeutic function in DDD. The significance and utilization of nutraceuticals, pharmaceuticals, and supplements to enhance bone health in DDD patients are highlighted in this chapter.